Validation of Serum Markers for Blood Brain Barrier Disruption in Traumatic Brain Injury
- 3 March 2009
- journal article
- Published by Mary Ann Liebert Inc in Journal of Neurotrauma
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?The Lancet Neurology, 2002
- Clinical Trials in Head InjuryJournal of Neurotrauma, 2002
- Transthyretin: a review from a structural perspectiveCellular and Molecular Life Sciences, 2001
- Cerebrospinal fluid analysis: disease-related data patterns and evaluation programsJournal of the Neurological Sciences, 2001
- Delivery of peptides and proteins through the blood–brain barrierAdvanced Drug Delivery Reviews, 2001
- S100b expression in and effects on microgliaGlia, 2001
- Traumatic axonal injury: practical issues for diagnosis in medicolegal casesNeuropathology and Applied Neurobiology, 2000
- Serum markers of brain damage and outcome prediction in patients after severe head injuryBritish Journal of Neurosurgery, 1999
- INTRACRANIAL HEMORRHAGE: DIAGNOSIS AND EMERGENCY MANAGEMENTNeurologic Clinics, 1998
- Drug Delivery to the BrainJournal of Cerebral Blood Flow & Metabolism, 1997